Insights

insight-blog-image
September 3, 2024
Healthcare M&A Weekly 9.3.24

A Look at Recent Transactions Shaping the Future of Healthcare

This week's article provides a summary of recent healthcare M&A news for September 3, 2024. 

The healthcare industry is rapidly evolving, with the lines between the healthcare technology and services sectors blurring - creating the catalyst for innovation, transformation, and continued market activity. TripleTree's Healthcare M&A Weekly summarizes recent mergers, acquisitions, and investments shaping the future of healthcare.

To view previous healthcare M&A activity, please review last week's post: Healthcare M&A Weekly - August 27, 2024.

  • Global private equity healthcare specialist ARCHIMED has acquired Irrimax Corporation (including its holding company, Innovation Technologies) for an undisclosed sum. Lawrenceville, GA-based Irrimax, founded in 2003, develops and markets Irrisept® Antimicrobial Wound Lavage, a market-leading solution within high performance wound irrigation. Read more about the acquisition here.

  • Cantata Health Solutions, a provider of healthcare technology solutions for behavioral health and human services providers, announced the acquisition of Geisler IT Services, provider of the Gosh System that enables Managed Care Organizations (MCOs) to collaborate with service providers to enroll clients, confirm eligibility, submit, process and adjudicate claims, and receive funding for services. Click here to view the announcement.

  • McKesson Corporation (NYSE: MCK) announced that it signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). Core Ventures, a business and administrative services organization, was established by Florida Cancer Specialists & Research Institute, LLC (FCS), a leading physician-owned community oncology practice. Learn more here.

  • MedHQ, a Westchester, IL-based provider of HR and financial management services to healthcare providers, has acquired Trajectory Revenue Cycle Services, a Wichita, KS-based, collaborative revenue cycle management service company. MedHQ is backed by private equity firm 424 Capital. Read more about the acquisition here.

  • Noetik, a San Francisco, CA-based biotechnology company driven by artificial intelligence, has raised $40M in an oversubscribed Series A financing round, led by Polaris Partners and managing partner Amy Schulman. Click here for more on the financing.

  • Platinum Equity announced the acquisition of a controlling stake in Inventia Healthcare Limited's core Oral Solid Dosage (OSD) business from India Life Sciences Fund III, NYLIM Jacob Ballas India Fund III, LLC, Mauritius and affiliates of the company's founding Shah family. Read more about the acquisition here.

  • StatLab Medical Products, a global developer and manufacturer of medical diagnostic supplies and equipment, announced that it has reached an agreement to acquire Diapath S.p.A., an Italian manufacturer of histology and cytology products and equipment. View the press release here.

  • VION Biosciences, a Charlottesville, VA-based life science platform company backed by Iron Path Capital, has acquired Ansh Labs, a Houston, TX-based biotechnology firm engaged in development and manufacturing of immunodiagnostic assays and reagents for research and diagnostics, marking its second acquisition this month. Read the announcement here.

Transactions outlined in this summary highlight some of the key trends shaping the future of healthcare. Get the latest industry news from TripleTree every week.

This is a partial list of transaction activity across the healthcare industry and is not intended to be a complete listing. Transaction information was identified from various sources and TripleTree may or may not have acted as the financial advisor for the transactions listed. All product names, logos and brands are property of their respective owners. All company, product and service names used in this communication are for identification purposes only. Use of these names, logos and brands does not imply endorsement.

SHARE ON

TAGS